Immunoglobulin level and antibody titer after immunization with staphylococcal anatoxin and plasmapheresis of donors
Korepanov, A.M.; Korepanov, A.A.; Sokolova, I.V.; Alypova, E.V.
Vrachebnoe Delo 6: 7-9
1986
ISSN/ISBN: 0049-6804 PMID: 3750968 Document Number: 269728
Document emailed within 1 workday
Related Documents
Demidova, N.V.; Vinogradova, I.L.; Krokhina, M.A.; Bagriantseva, S.I. 1977: Acid-base equilibrium of venous blood of donors after immunization with staphylococcal toxoid and plasmapheresis Problemy Gematologii i Perelivaniia Krovi 22(10): 49-52Bel'skiĭ, V.V.; Zakarian, L.M.; Prokopenko, L.G.; Chalyĭ, G.A. 1988: Effect of terrilytin on the activity of nonspecific resistance factors during immunization with staphylococcal anatoxin and staphylococcal infection Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 90-95
Krutitskaia, L.I.; Zhebrun, A.B. 1996: The characteristics of the autoimmune reactions in donors immunized with influenza vaccine and staphylococcal anatoxin Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 44-47
Spasokukotskiĭ, A.I.; Kogosov, I.A.; Kvachuk, G.N.; Spisarenko, S.P.; Karnakh, R.I. 1973: Comparative evaluation of different doses of staphylococcal anatoxin in the immunization of patients wit heart defects Vrachebnoe Delo 8: 58-61
Revenko, T.A.; Rushaĭ, A.K.; Babosha, V.A.; Kaplan, A.E. 1982: Preventive express immunization with staphylococcal anatoxin in open fractures of long tubular bones Ortopediia Travmatologiia i Protezirovanie 1982(1): 9-11
Namba, K.; Ogawa, T.; Nishiyama, Y.; Sawada, K. 1992: Antibody titer to streptococcal and staphylococcal L-form in Behçet's disease and other uveitis Nippon Ganka Gakkai Zasshi 96(10): 1286-1289
Kardovich, G.A.; Berenshteĭn, T.F.; Daniushchenkova, N.M. 1980: Effect of lincomycin, chymotrypsin and their combinations on the splenic plasmacytic reaction and the antibody titer in experimental staphylococcal infection Antibiotiki 25(8): 606-609
Manolova, E.P.; Tret'iakevich, Z.N.; Khripko, S.V. 1989: The creation of specific immunity to staphylococcal infection in newborn infants by the intranasal administration of adsorbed staphylococcal anatoxin Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 8: 64-67
Sumarokov, A.A.; Lelikov, V.L.; Ivanov, N.R.; Poliakov, K.A.; Dzhaparidze, M.H. 1974: Study of the immunogenicity and immunological effectiveness of choleragen anatoxin. (data from a controlled epidemiological experiment). 3. the determination of the optimum inoculation doses of choleragen anatoxin for the immunization of children of different ages and of adolescents Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 12: 32-38
Schadde, E.; d'Alessandro, A.M.; Musat, A.I.; Torrealba, J.R.; Knechtle, S.J. 2006: Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin Clinical Transplants 2006: 479-482
Terness, P.; Süsal, C.; Opelz, G. 1989: IgG-anti-immunoglobulin induced by immunization with antibody-coated blood cells: mechanism for B-cell suppression? Transplantation Proceedings 21(1 Pt 1): 153-155
Lutowiecka-Wranicz, A.; Kulesza, K.; Czerneilewski, J. 1978: Treatment of purulent skin diseases with staphylococcal anatoxin Przeglad Dermatologiczny 65(5): 583-588
Gong, Z.; Weng, J.; Zhao, Z.; Lan, J.; Chen, Y.; Lin, C.; Fu, G.; Zhu, Z.; Xia, J.; Ji, Q.; Xu, J.; Wang, C.; Yu, X.; Wang, W.; Fang, C. 2000: The changes in serum antibody level after immunization with HFRS vaccine Zhonghua Yu Fang Yi Xue Za Zhi 34(6): 351-353
Blottière, H.M.; Douillard, J.Y.; Koprowski, H.; Steplewski, Z. 1990: Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients Cancer Research 50(3 Suppl): 1051s-1054s
Proskurov, V.A. 1971: Desensitizing effect of autovaccino- and anatoxin therapy in staphylococcal infections Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 48: 46-48
Povazhenko, A.A.; Sorokin, I.V.; Sorokina, E.P. 1986: Characteristics of the immune response to staphylococcal anatoxin in healthy persons Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 7: 92-96
Hirunpetcharat, C.; Tian, J.H.; Kaslow, D.C.; van Rooijen, N.; Kumar, S.; Berzofsky, J.A.; Miller, L.H.; Good, M.F. 1997: Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells Journal of Immunology 159(7): 3400-3411
Lebedev, A.A.; Prozorovskaia, K.N.; Antonova, L.V. 1973: Use of staphylococcal anatoxin for treating and preventing inflammatory diseases of the female sex organs Akusherstvo i Ginekologiia 49(3): 20-22
Semenova, I.B.; Akatov, A.K. 1990: The characteristics of the protective and antigenic activities of purified staphylococcal anatoxin in trials with mice of different genotypes Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 80-85
Lesnitskiĭ, A.I. 1986: Clinico-immunological assessment of the effectiveness of staphylococcal anatoxin and the indications for its use in chronic pyoderma patients Vestnik Dermatologii i Venerologii 4: 11-16